Greece: Patent system moves towards substantive examination

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Patent system moves towards substantive examination

Sponsored by

patrinos-logo.png
lianhao-qu-lfan1gswv5c-unsplash.jpg

Constantinos Kilimiris of Patrinos & Kilimiris explains how a recent amendment in the provisions of the Greek patent law resolves a long-standing issue which prevented amending applications

The Greek patent system is one that does not provide for substantive examination of patent applications. A national patent application will receive formalities examination and, upon payment of the search fees, a search report on prior art will be provided with the option of obtaining a reasoned opinion from the examiner. The patent will be granted, upon payment of the grant fees, and the search report will be published together with the granted patent.

The validity of such patents can be challenged at court by any third party either in nullity proceedings, or as a defense, in infringement proceedings. In this way, substantive examination on patentability is in practice deferred until a patent is actually litigated and the court will have the chance to rule on patentability on the basis of the search report and opinion accompanying the granted patent.

One of the problems arising with the above patent system was that, upon receipt of the search report, the applicant did not have the possibility to amend his application in order to address the examiner’s objections based on the prior art cited.

This problem has now been resolved with a recent amendment in the provisions of the Greek patent law (1733/87). According to the new provisions, the applicant now has the possibility, within three months from receipt of the search report, to limit his application by submitting amendments in the claims and description addressing the prior art cited.

The examiner will consider the amended claims and draft a final search report that will be published with the granted patent.

While the recent amendments in the patent law still do not provide for substantive examination, they do provide the applicant with the possibility of limiting his application and obtaining a favourable search report, without the need to do so in litigation proceedings.

This seems to take a step towards the introduction of a long-awaited substantive examination patent system in Greece.

 

Constantinos KilimirisPartner, Patrinos & KilimirisE: ckilimiris@patrinoskilimiris.com

more from across site and SHARED ros bottom lb

More from across our site

The US decision marks a rare grant of a request under the Uniform Fraudulent Transfer Act in a patent case
Stobbs has applied to strike out a contempt of court application filed against the firm and two of its lawyers
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
A lack of comfort among some salaried partners shows why law firms must actively foster inclusion, not merely focus on diversity mandates
Arrival of Laura Alonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
Gift this article